Frontiers | Molecular Biomarkers for Melanoma Screening, Diagnosis and Prognosis: Current State and Future Prospects
Serologic Markers of Malignant Melanoma | Download Table
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
Tumor markers in clinical practice Colorectal - CEA Hepatocellular ... | GrepMed
Diagnostic and Prognostic Biomarkers in Melanoma – JCAD | The Journal of Clinical and Aesthetic Dermatology
Cureus | The Role of Biomarkers in the Diagnosis and Prognosis of Different Stages of Melanoma | Article
Biomarkers in Malignant Melanoma: Recent Trends and Critical Perspective - Cutaneous Melanoma - NCBI Bookshelf
Melanoma | Encyclopedia MDPI
A diagnostic algorithm to distinguish desmoplastic from spindle cell melanoma | Modern Pathology
Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance - ScienceDirect
Phenotyping of Human Melanoma Cells Reveals a Unique Composition of Receptor Targets and a Subpopulation Co-Expressing ErbB4, EPO-R and NGF-R | PLOS ONE
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
Frontiers | Current Trends in Circulating Biomarkers for Melanoma Detection
Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine - ScienceDirect
Cells | Free Full-Text | Molecular Markers and Targets in Melanoma